Comprehensive Psychiatry
Volume 48, Issue 2 , Pages 145-154 , March 2007

The interface between borderline personality disorder and bipolar spectrum disorders

  • Joel Paris

      Affiliations

    • Department of Psychiatry, Institute of Community and Family Psychiatry, SMBD-Jewish General Hospital, McGill University, Montreal, Québec, Canada H3T 1E4
    • Corresponding Author InformationCorresponding author.
  • ,
  • John Gunderson

      Affiliations

    • Department of Psychiatry, McLean Hospital, Harvard University, Boston, MA 02478, USA
  • ,
  • Igor Weinberg

      Affiliations

    • Department of Psychiatry, McLean Hospital, Harvard University, Boston, MA 02478, USA

References 

  1. Akiskal HS, Chen SE, Davis GC. Borderline: an adjective in search of a noun. J Clin Psychiatry. 1985;46:41–48
  2. Stone MH. The borderline syndromes: constitution, personality, and adaptation. New York: McGraw Hill; 1980;
  3. Liebowitz MR, Klein DF. Interrelationship of hysteroid dysphoria and borderline personality disorder. Psychiatr Clin North Am. 1981;4:67–87
  4. Zanarini MC, Gunderson JG, Frankenburg FR. Axis I phenomenology of borderline personality disorder. Compr Psychiatry. 1989;30:149–156
  5. Zanarini MC, Frankenburg FR, Dubo ED, Sickel AE, Trikha A, Levin A, et al. Axis I comorbidity of borderline personality disorder. Am J Psychiatr. 1998;155:1733–1739
  6. Gunderson JG. Borderline personality disorder: a clinical guide. Washington (DC): American Psychiatric Press; 2001;
  7. Skodol AE, Gunderson JG, Pfohl B, Widiger TA, Livesley WJ, Siever LJ. The borderline diagnosis I: psychopathology, comorbidity, and personality structure. Biol Psychiatry. 2002;51:936–950
  8. Gunderson JG, Elliott GR. The interface between borderline personality disorder and affective disorder. Am J Psychiatr. 1985;142:279–288
  9. Gunderson JG, Phillips KA. A current view of the interface between borderline personality disorder and depression. Am J Psychiatr. 1991;148:967–975
  10. Koenigsberg HW, Kaplan RD, Gilmore MM, Cooper AM. The relationship between syndrome and personality disorder in DSM-III: experience with 2,462 patients. Am J Psychiatr. 1985;142:207–212
  11. White CN, Gunderson JG, Zanarini MC, Hudson JI. Family studies of borderline personality disorder: a review. Harv Rev Psychiatry. 2003;12:118–119
  12. Gunderson JG, Morey LC, Stout RL, Skodol AE, Shea MT, McGlashan TH, et al. Major depressive disorder and borderline personality disorder revisited: longitudinal interactions. J Clin Psychiatry. 2004;65:1049–1056
  13. Akiskal HS. The bipolar spectrum: the shaping of a new paradigm in psychiatry. Curr Psychiatry Rep. 2002;4:1–3
  14. Perugi G, Toni C, Travierso MC, Akiskal HS. The role of cyclothymia in atypical depression: toward a data-based reconceptualization of the borderline bipolar II connection. J Affect Disord. 2003;73:87–98
  15. Akiskal HS, Benazzi F. Family history validation of the bipolar nature of depressive mixed states. J Affect Disord. 2003;73:113–122
  16. Akiskal HS, Hantouche EG, Allilaire JF. Bipolar II with and without cyclothymic temperament: “dark” and “sunny” expressions of soft bipolarity. J Affect Disord. 2003;73:49–57
  17. Akiskal HS. The prevalent clinical spectrum of bipolar disorders: beyond DSM-IV. J Clin Psychopharmacol. 1996;16:4–14
  18. Angst J, Gamma A. A new bipolar spectrum concept: a brief review. Bipolar Disord. 2002;4:11–14
  19. Ghaemi SN, Ko JY, Goodwin FK. “Cade's disease” and beyond: misdiagnosis, antidepressant use, and a proposed definition for bipolar spectrum disorder. Can J Psychiatry. 2002;47:125–134
  20. Howland RH, Thase ME. A comprehensive review of cyclothymic disorder. J Nerv Ment Dis. 1993;181:485–493
  21. Perugi G, Akiskal HS. The soft bipolar spectrum redefined: focus on the cyclothymic, anxious-sensitive, impulse-dyscontrol, and binge-eating connection in bipolar II and related conditions. Psychiatr Clin North Am. 2002;25:713–737
  22. Akiskal HS. Demystifying borderline personality: critique of the concept and unorthodox reflections on its natural kinship with the bipolar spectrum. Acta Psychiatr Scand. 2004;110:401–407
  23. Pope HG, Jonas JM, Hudson JI, Cohen BM, Gunderson JG. The validity of DSM-III BPD. Arch Gen Psychiatry. 1983;40:23–30
  24. McGlashan TH. The chestnut lodge follow-up study. III. Long-term outcome of borderline personalities. Arch Gen Psychiatry. 1986;43:20–30
  25. Links PS, Steiner M, Offord DR, Eppel A. Characteristics of borderline personality disorder: a Canadian study. Can J Psychiatry. 1988;33:336–340
  26. Alnaes R, Torgersen S. Personality and personality disorders among patients with various affective disorders. J Pers Disord. 1991;5:107–121
  27. Hudziak JJ, Boffeli TJ, Kreisman JJ, Battaglia MM. Clinical study of the relation of borderline personality disorder to Briquet's syndrome (hysteria), somatization disorder, antisocial personality disorder, and substance abuse disorders. Am J Psychiatr. 1996;153:1598–1606
  28. Zimmerman M, Mattia JI. Axis I diagnostic comorbidity and borderline personality disorder. Compr Psychiatry. 1999;40:245–252
  29. Deltito J, Martin L, Riefkohl J, Austria B, Kissilenko A, Corless C, et al. Do patients with borderline personality disorder belong to the bipolar spectrum?. J Affect Disord. 2001;67:221–228
  30. McGlashan TH, Grilo CM, Skodol AE, Gunderson JG, Shea MT, Morey LC, et al. The collaborative longitudinal personality disorders study: baseline axis I/II and II/II diagnostic co-occurrence. Acta Psychiatr Scand. 2000;102:256–264
  31. Akiskal HS. Borderline: an adjective still in search of a noun. In:  Silver D,  Rosenbluth M editor. Handbook of borderline disorders. Madison CN: International Universities Press; 1992;p. 155–177
  32. Levitt AJ, Joffe RT, Ennis J, MacDonald C, Kutcher SP. The prevalence of cyclothymia in borderline personality disorder. J Clin Psychiatry. 1990;51:335–339
  33. Gavria M, Faherty J, Val E. A comparison of bipolar patients with and without a borderline personality disorder. Psychiatr J Univ Ott. 1982;7:190–195
  34. Koenisgberg HW, Harvey PD, Mitropolou V, Schmeidler J, New AS, Goodman M, et al. Characterizing affective instability in borderline personality disorder. Am J Psychiatr. 2002;159:784–788
  35. Jackson HJ, Whiteside HL, Bates GW, Bell R, Rudd RP, Edwards J. Diagnosing personality disorders in psychiatric inpatients. Acta Psychiatr Scand. 1990;83:206–213
  36. Pica S, Edwards J, Jackson HJ, Bell RC, Bates GW, Rudd RP. Personality disorder in recent-onset bipolar disorder. Compr Psychiatry. 1990;31:499–510
  37. O'Connell RA, Mayo JA, Sciutto MS. PDQ-R personality disorders in bipolar patients. J Affect Disord. 1991;23:217–221
  38. Turley B, Bates GW, Edwards J, Jackson HJ. MCMI-II personality disorders in recent-onset bipolar disorders. J Clin Psychol. 1992;48:320–329
  39. Peselow ED, Sanfilipo MP, Fieve RR. Relationship between hypomania and personality disorders before and after successful treatment. Am J Psychiatr. 1995;152:232–238
  40. Ucok A, Karaveli D, Kundakci T, Yazici O. Comorbidity of personality disorders with bipolar mood disorders. Compr Psychiatry. 1998;39:72–74
  41. Vieta E, Colom F, Martinez-Aran A, Benabarre A, Gasto C. Personality disorders in bipolar II patients. J Nerv Ment Dis. 1999;187:245–248
  42. Benazzi F. BPD and bipolar II disorder in private practice depressed outpatients. Compr Psychiatry. 2000;41:106–110
  43. Vieta E, Colom F, Corbella B, Martinez-Aran A, Reinares M. Clinical correlates of psychiatric comorbidity in bipolar I patients. Bipolar Disord. 2001;3:253–258
  44. Rossi A, Marinageli MG, Butti G, Scinto A, Cicco LD, Kalyvoka A, et al. Personality disorders in depressed and depressive disorders. J Affect Disord. 2001;65:3–8
  45. Brieger P, Ehrt U, Marneros A. Frequency of comorbid personality disorders in bipolar and unipolar affective disorders. Compr Psychiatry. 2003;44:28–34
  46. George EL, Miklowitz DJ, Richards JA, Simoneau TL, Taylor DO. The comorbidity of bipolar disorder and axis II personality disorders: prevalence and clinical correlates. Bipolar Disord. 2003;5:115–122
  47. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the national comorbidity survey. Arch Gen Psychiatry. 1994;51:8–19
  48. Samuels J, Eaton WW, Bienvenu J, Clayton P, Brown H, Costa PT, et al. Prevalence and correlates of personality disorders in a community sample. Br J Psychiatry. 2002;180:536–542
  49. Torgersen S, Kringlen E, Cramer V. The prevalence of personality disorders in a community sample. Arch Gen Psychiatry. 2001;58:590–596
  50. Hirschfeld RM, Calabrese JR, Weissman MM, Reed M, Davies MA, Frye MA, et al. Screening for bipolar disorder in the community. J Clin Psychiatr. 2003;64:53–59
  51. Angst J. The emerging epidemiology of hypomania and bipolar II disorder. J Affect Disord. 1998;50:143–151
  52. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 4th ed., text revision. Washington (DC): American Psychiatric Press; 2000;
  53. Livesley WJ, Jang KL, Jackson DN, Vernon PA. Genetic and environmental contributions to dimensions of personality disorder. Am J Psychiatr. 1993;150:1826–1831
  54. Linehan MM. Dialectical behavioral therapy of borderline personality disorder. New York: Guilford; 1993;
  55. Zanarini MC, Frankenburg FR, Hennen J, Silk KR. The longitudinal course of borderline psychopathology: 6-year prospective follow-up of the phenomenology of borderline personality disorder. Am J Psychiatr. 2003;160:274–283
  56. Paris J, Zweig-Frank H. A twenty-seven year follow-up of borderline patients. Compr Psychiatry. 2001;42:482–487
  57. Shea MT, Stout RL, Yen S, Pagano ME, Skodol AE, Morey LC, et al. Associations in the course of personality disorders and Axis I disorders over time. J Abnorm Psychol. 2004;113:499–508
  58. In:  Costa PT,  Widiger TA editor. Personality disorders and the five-factor model of personality. 2nd ed.. Washington (DC): American Psychological Association; 2001;
  59. Morey LC, Gunderson JG, Quigley BD, Shea MT, Skodol AE, McGlashan TH, et al. The representation of borderline, avoidant, obsessive-compulsive, and schizotypal personality disorders by the five-factor model. J Pers Disord. 2002;16:215–234
  60. Furukawa T, Hori S, Yoshida S, Tsuji M, Nakanishi M, Hamanaka T. Premorbid personality traits of patients with organic (ICD-10 F0), schizophrenic (F2), mood (F3), and neurotic (F4) disorders according to the five-factor model of personality. Psychiatry Res. 1998;78:179–188
  61. Bagby RM, Bindseil KD, Schuller DR, Rector NA, Young LT, Cooke RG, et al. Relationship between the five-factor model of personality and unipolar, bipolar and schizophrenic patients. Psychiatry Res. 1997;70:83–94
  62. Atre-Vaidya N, Hussain SM. Borderline personality disorder and bipolar mood disorder: two distinct disorders or a continuum. J Nerv Ment Dis. 1999;187:313–357
  63. Henry C, Mitropoulou V, New AS, Koenigsberg HW, Silverman J, Siever LJ. Affective instability and impulsivity in borderline personality and bipolar II disorders: similarities and differences. J Psychiatr Res. 2001;35:307–312
  64. Malkoff-Schwartz S, Frank E, Anderson BP, Hlastala SA, Luther JF, Sherrill JT, et al. Social rhythm disruption and stressful life events in the onset of bipolar and unipolar episodes. Psychol Med. 2000;30:1005–1016
  65. Dunner DI, Tay KL. Diagnostic reliability of the history of hypomania in bipolar II patients and patients with major depression. Compr Psychiatry. 1993;34:303–307
  66. Herpertz SC, Kunert HJ, Schwenger UB, Sass H. Affective responsiveness in borderline personality disorder: a psychophysiological approach. Am J Psychiatr. 1999;156:1550–1556
  67. MacKinnon DF, Zandi PP, Gershon E, NurnbergerJr JI, Reich T, DePaulo JR. Rapid switching of mood in families with multiple cases of bipolar disorder. Arch Gen Psychiatry. 2003;60:921–928
  68. Swann AC, Pazzaglia P, Nicholls A, Dougherty DM, Moeller FG. Impulsivity and phase of illness in bipolar disorder. J Affect Disord. 2003;73:105–111
  69. Links PS, Heslegrave R, van Reekum R. Impulsivity: core aspect of borderline personality disorder. J Pers Disord. 1999;13:131–139
  70. Moeller FG, Barratt ES, Dougherty DM, Schmitz JM, Swann AC. Psychiatric aspects of impulsivity. Am J Psychiatr. 2001;158:1783–1793
  71. Swann AC, Dougherty DM, Pazzaglia PJ, Pham M, Moeller FG. Impulsivity: a link between bipolar disorder and substance abuse. Bipolar Disord. 2004;6:204–212
  72. Brown MZ, Comtois KA, Linehan MM. Reasons for suicide attempts and nonsuicidal self-injury in women with borderline personality disorder. J Abnorm Psychol. 2002;111:198–202
  73. Agrawal HR, Gunderson J, Holmes BM, Lyons-Ruth K. Attachment studies with borderline patients: a review. Harv Rev Psychiatr. 2004;12:94–104
  74. Meyer B, Pilkonis PA, Proietti JM, Heape CL, Egan M. Attachment styles and personality disorders as predictors of symptom course. J Pers Disord. 2001;15:371–389
  75. Akiskal HS. Subaffective disorders: dysthymic, cyclothymic and bipolar II disorders in the “borderline” realm. Psychiatr Clin North Am. 1981;4:25–46
  76. Stone MH. The Borderline Syndrome: evolution of the term, genetic aspects, and prognosis. Am J Psychother. 1979;31:345–365
  77. Stone MH, Kahn E, Flye B. Psychiatrically ill relatives of borderline patients: a family study. Psychiatr Q. 1981;53:71–84
  78. Loranger AW, Oldham JM, Tulis EH. Familial transmission of DSM-III borderline personality disorder. Arch Gen Psychiatry. 1982;39:795–799
  79. Links PS, Steiner B, Huxley G. The occurrence of borderline personality disorder in the families of borderline patients. J Pers Disord. 1988;2:14–20
  80. Zanarini MC, Gunderson JG, Marino MF, Schwartz EO, Frankenburg FR. DSM III disorders in the families of borderline outpatients. J Pers Disord. 1988;2:292–302
  81. Schulz PF, Soloff PH, Kelly T, Morgensterm M, Franco DR, Schulz SC. A family history study of borderline subtypes. J Pers Disord. 1989;3:217–229
  82. Silverman JM, Pinkham L, Horvath TB, Coccaro ER, Klar H, Schear S, et al. Affective and impulsive personality disorder traits in the relatives of patients with borderline personality disorder. Am J Psychiatr. 1991;148:1378–1385
  83. Riso LP, Klein DN, Anderson RL, Ouimette PC. A family study of outpatients with borderline personality disorder and no history of mood disorder. J Pers Disord. 2000;14:208–217
  84. Kelsoe JR. Arguments for the genetic basis of the bipolar spectrum. J Affect Disord. 2003;73:183–197
  85. Coryell W, Endicott J, Reich T, Andreasen N, Keller M. A family study of bipolar II disorder. Br J Psychiatry. 1984;145:49–54
  86. Soloff P. Psychopharmacological treatment of borderline personality disorder. Psychiatr Clin North Am. 2000;23:169–192
  87. Thase ME, Sachs GS. Bipolar depression: pharmacotherapy and related therapeutic strategies. Biol Psychiatry. 2000;48:558–572
  88. Soloff PH, George A, Nathan S, Schulz PM, Cornelius JR, Herring J, et al. Amitriptyline versus haloperidol in borderlines: final outcomes and predictors of response. J Clin Psychopharmacol. 1989;9:238–246
  89. Soloff PH, George A, Nathan S. Efficacy of phenelzine and haloperidol in borderline personality disorder. Arch Gen Psychiatry. 1993;143:1603–1605
  90. Markowitz PJ. Pharmacotherapy of impulsivity, aggression, and related disorders. In:  Hollander E,  Stein DJ editor. Impulsivity and aggression. New York: John Wiley; 1995;p. 263–286
  91. Salzman C, Wolfson AN, Schatzberg A, Looper J, Henke R, Albanese M, et al. Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder. J Clin Psychopharmacol. 1995;15:23–29
  92. Coccaro EF, Kavoussi RJ. Fluoxetine and impulsive aggressive behavior in personality-disordered subjects. Arch Gen Psychiatry. 1997;54:1081–1088
  93. Rinne T, van den Brink W, Wouters L, van Dyck R. SSRI treatment of borderline personality disorder: a randomized, placebo-controlled clinical trial for female patients with borderline personality disorder. Am J Psychiatr. 2002;159:2048–2054
  94. Zanarini MC, Frankenburg FR, Parachini EA. A preliminary, randomized trial of fluoxetine, olanzapine, and the olanzapine-fluoxetine combination in women with borderline personality disorder. J Clin Psychiatry. 2004;65:903–907
  95. Chun BJ, Dunner DL. A review of antidepressant-induced hypomania in major depression: suggestions for DSM-V. Bipolar Disord. 2004;6:32–42
  96. Moller HJ, Nasrallah HA. Treatment of bipolar disorder. J Clin Psychiatry. 2003;64:9–17
  97. Coryell W, Solomon D, Turvey C, Keller M, Leon AC, Endicott J, et al. The long-term course of rapid-cycling bipolar disorder. Arch Gen Psychiatry. 2003;60:914–920
  98. Goodwin FK. Rationale for long-term treatment of bipolar disorder and evidence for long-term lithium treatment. J Clin Psychiatry. 2002;63:5–12
  99. Suppes T, Dennehy DB. Evidence-based treatment of bipolar II disorder. J Clinical Psychiatry. 2002;63:29–33
  100. Links PS, Steiner M, Boiago I, Irwin D. Lithium therapy for borderline patients: preliminary findings. J Pers Disord. 1990;4:173–181
  101. Evins AE. Efficacy of newer anticonvulsant medications in bipolar spectrum mood disorders. J Clin Psychiatry. 2003;64:9–14
  102. Hadjipavlou G, Mok H, Yatham LN. Pharmacotherapy of bipolar II disorder: a critical review of current evidence. Bipolar Disord. 2004;6:14–25
  103. Cowdry RW, Gardner DL. Pharmacotherapy of borderline personality disorder: alprazolam, carbamazepine, trifluoperazine, and tranylcypromine. Arch Gen Psychiatry. 1988;45:111–119
  104. Hollander E, Allen A, Lopez RP, Bienstock CA, Grossman R, Siever LJ, et al. A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder. J Clin Psychiatry. 2001;62:199–203
  105. Hollander E, Swann AC, Coccaro EF, Jiang P, Smith TB. Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorder. Am J Psychiatr. 2005;162:621–624
  106. Frankenburg FR, Zanarini MC. Divalproex sodium treatment of women with borderline personality disorder and bipolar II disorder: a double-blind placebo controlled pilot study. J Clin Psychiatry. 2002;63:442–446
  107. Zanarini MC, Frankenburg FR. Olanzapine treatment of female borderline personality disorder patients: a double-blind, placebo-controlled pilot study. J Clin Psychiatry. 2001;62:849–854
  108. Bogenschutz MP, Nurnberg GH. Olanzapine versus placebo in the treatment of borderline personality disorder. J Clin Psychiatry. 2004;65:104–109
  109. Hirschfeld RM. The efficacy of atypical antipsychotics in bipolar disorders. J Clin Psychiatry. 2003;64:15–21
  110. Yatham LN. Efficacy of atypical antipsychotics in mood disorders. J Clin Psychopharmacol. 2003;23:S9–S14
  111. Stone MH. The fate of borderline patients. New York: Guilford; 1990;
  112. Links PS, Heslegrave RJ, Mitton JE, VanReekum R, Patrick J. Borderline psychopathology and recurrences of clinical disorders. J Nerv Ment Dis. 1995;183:582–586
  113. Bernstein DP, Cohen P, Skodol A, Bezirganian S, Book JS. Prevalence and stability of the DSM-III personality disorders in a community based survey of adolescents. Am J Psychiatr. 1993;150:1237–1243
  114. Rey JM, Singh M, Morris-Yates A, Andrews G. Referred adolescents as young adults: The relationship between psychosocial functioning and personality disorder. Aust N Z J Psychiatry. 1997;31:219–226
  115. Grilo CM, Sanislow CA, Gunderson JG, Pagano ME, Yen S, Zanarini MC, et al. Two-year stability and change of schizotypal, borderline, avoidant, and obsessive-compulsive personality disorders. J Consult Clin Psychol. 2004;72:767–775
  116. Gunderson JG, Weinberg I, Daversa MT, Kueppenbender KD, Zanarini MC, Shea MT, et al. Descriptive and longitudinal observations on the relationship of borderline personality disorder and bipolar disorder. Am J Psychiatr. 2006;163:1173–1178
  117. Goldberg JF, Garno JL, Harrow M. Long-term remission and recovery in bipolar disorder: a review. Curr Psychiatry Rep. 2005;7:456–461
  118. Solomon DA, Leon AC, Endicott J, Coryell WH, Mueller TI, Posternak MA, et al. Unipolar mania over the course of a 20-year follow-up study. Am J Psychiatr. 2003;160:2049–2051
  119. Judd LL, Schettler PJ, Akiskal HS, Maser J, Coryell W, Solomon D, et al. Long-term symptomatic status of bipolar I vs. bipolar II disorders. Int J Neuropsychopharmacol. 2003;6:127–137
  120. Coryell W, Solomon D, Turvey C, Keller M, Leon AC, Endicott J, et al. The long-term course of rapid-cycling bipolar disorder. Arch Gen Psychiatry. 2003;60:914–920
  121. Kwapil TR, Miller MB, Zinser MC, Chapman LJ, Chapman J, Eckblad M. A longitudinal study of high scorers on the hypomanic personality scale. J Abnorm Psychology. 2000;109:222–226
  122. Joyce PR, McKenzie JM, Luty SE, Mulder RT, Carter JD, Sullivan PF, et al. Temperament, childhood environment and psychopathology as risk factors for avoidant and borderline personality disorders. Aust N Z J Psychiatry. 2003;37:756–764
  123. Jang KL, Livesley WJ, Vernon PA, Jackson DN. Heritability of personality traits: a twin study. Acta Psychiatr Scand. 1996;94:438–444
  124. Zuckerman M. Sensation seeking and impulsivity: a marriage of traits made in biology?. In:  McCown WG,  Johnson JL editor. The impulsive client: theory, research, and treatment. Washington (DC): American Psychological Association; 1993;p. 71–91
  125. Torgersen S, Lygren S, Oien PA, Skre I, Onstad S, Edvardsen J, et al. A twin study of personality disorders. Compr Psychiatry. 2000;41:416–425
  126. Mann JJ. The neurobiology of suicide. Nat Med. 1998;4:25–30
  127. Pooley EC, Houston K, Hawton K, Harrison PJ. Deliberate self-harm is associated with allelic variation in the tryptophan hydroxylase gene (TPH A779C), but not with polymorphisms in five other serotonergic genes. Psychol Med. 2003;33:775–783
  128. Siever LJ, Torgersen S, Gunderson JG, Livesley WJ, Kendler KS. The borderline diagnosis III: identifying endophenotypes for genetic studies. Biol Psychiatry. 2002;51:964–968
  129. Paris J, Zweig-Frank H, Ng F, Schwartz G, Steiger H, Nair V. Neurobiological correlates of diagnosis and underlying traits in patients with borderline personality disorder compared with normal controls. Psychiatry Res. 2004;121:239–252
  130. Gurvits IG, Koenisgberg HW, Siever LJ. Neurotransmitter dysfunction in patients with borderline personality disorder. Psychiatr Clin North Am. 2000;23:27–40
  131. Strakowski SM, DelBello MP, Zimmerman ME, Getz GE, Mills NP, Ret J, et al. Ventricular and periventricular structural volumes in first- versus multiple-episode bipolar disorder. Am J Psychiatr. 2002;159:1841–1847
  132. Lyoo IK, Han MH, Cho DY. A brain MRI study in subjects with borderline personality disorder. J Affect Disord. 1998;50:235–243
  133. Driessen M, Herrmann J, Stahl K, Zwaan M, Meier S, Hill A, et al. Magnetic resonance imaging volumes of the hippocampus and the amygdala in women with borderline personality disorder and early traumatization. Arch Gen Psychiatry. 2000;57:1115–1122
  134. Tebartz van Elst L, Hesslinger B, Thiel T, Geiger E, Haegele K, Lemieux L, et al. Frontolimbic brain abnormalities in patients with borderline personality disorder: a volumetric magnetic resonance imaging study. Biol Psychiatry. 2003;54:163–171
  135. Tebartz van Elst L, Ludaescher P, Wilke M, Huppertz HJ, Thiel T, Schmahl C, et al. A voxel-based morphometric MRI study in female patients with borderline personality disorder. Neuroimage. 2003;20:385–392
  136. Schmahl CG, Vermetten E, Elzinga BM, Bremner DJ. Magnetic resonance imaging of hippocampal and amygdala volume in women with childhood abuse and borderline personality disorder. Psychiatry Res. 2003;122:193–198
  137. Hauser P, Matochik J, Altshuler LL, Denicoff KD, Conrad A, Li X, et al. MRI-based measurements of temporal lobe and ventricular structures in patients with bipolar I and bipolar II disorders. J Affect Disord. 2000;60:25–32
  138. Payne JL, Potash JB, DePaulo JR. Recent findings on the genetic basis of bipolar disorder. Psychiatr Clin North Am. 2005;28:481–498
  139. Zanarini MC. Childhood experiences associated with the development of borderline personality disorder. Psychiatr Clin North Am. 2000;23:89–101
  140. Yen S, Shea MT, Battle CL, Johnson DM, Zlotnick C, Dolan-Sewell R, et al. Traumatic exposure and posttraumatic stress disorder in borderline, schizotypal, avoidant, and obsessive-compulsive personality disorders: findings from the collaborative longitudinal personality disorders study. J Nerv Ment Dis. 2002;190:510–518
  141. Leverich GS, McElroy SL, Suppes T, Keck PE, Denicoff KD, Nolen WA, et al. Early physical and sexual abuse associated with an adverse course of bipolar illness. Biol Psychiatry. 2002;51:288–297
  142. Kessler RC, Rubinow DR, Holmes C. The epidemiology of DSM-III-R bipolar 1 disorder in a general population survey. Psychol Med. 1997;27:1079–1089
  143. Sasson Y, Chopra M, Harrari E, Amitai K, Zohar J. Bipolar comorbidity: from diagnostic dilemmas to therapeutic challenge. Int J Neuropsychopharmacol. 2003;6:139–144
  144. Tyrer P, Gunderson J, Lyons M, Tohen M. Extent of comorbidity between mental state and personality disorders. J Pers Disord. 1997;11:242–259

PII: S0010-440X(06)00107-6

doi: 10.1016/j.comppsych.2006.10.001

Comprehensive Psychiatry
Volume 48, Issue 2 , Pages 145-154 , March 2007